Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
Clinical trial NCT06676033 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06676033
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2027-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.